» Articles » PMID: 30514834

Epigenetically Reprogrammed Methylation Landscape Drives the DNA Self-assembly and Serves As a Universal Cancer Biomarker

Overview
Journal Nat Commun
Specialty Biology
Date 2018 Dec 6
PMID 30514834
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Epigenetic reprogramming in cancer genomes creates a distinct methylation landscape encompassing clustered methylation at regulatory regions separated by large intergenic tracks of hypomethylated regions. This methylation landscape that we referred to as Methylscape is displayed by most cancer types, thus may serve as a universal cancer biomarker. To-date most research has focused on the biological consequences of DNA Methylscape changes whereas its impact on DNA physicochemical properties remains unexplored. Herein, we examine the effect of levels and genomic distribution of methylcytosines on the physicochemical properties of DNA to detect the Methylscape biomarker. We find that DNA polymeric behaviour is strongly affected by differential patterning of methylcytosine, leading to fundamental differences in DNA solvation and DNA-gold affinity between cancerous and normal genomes. We exploit these Methylscape differences to develop simple, highly sensitive and selective electrochemical or colorimetric one-step assays for the detection of cancer. These assays are quick, i.e., analysis time ≤10 minutes, and require minimal sample preparation and small DNA input.

Citing Articles

SERS-Based Assessment of DNA Methylation for the Evaluation of Measurable Residual Disease in Acute Promyelocytic Leukaemia.

Bancos A, Iancu S, Moisoiu V, Ghiaur A, Tigu A, Buran C J Cell Mol Med. 2025; 29(5):e70244.

PMID: 40042091 PMC: 11880916. DOI: 10.1111/jcmm.70244.


Ultrasensitive Amplification-Free Quantification of a Methyl CpG-Rich Cancer Biomarker by Single-Molecule Kinetic Fingerprinting.

Dai L, Johnson-Buck A, Laird P, Tewari M, Walter N Anal Chem. 2024; 96(43):17209-17216.

PMID: 39425638 PMC: 11648273. DOI: 10.1021/acs.analchem.4c03002.


The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization.

Bronkhorst A, Holdenrieder S Med Genet. 2024; 35(4):201-235.

PMID: 38835739 PMC: 11006350. DOI: 10.1515/medgen-2023-2065.


Applications of Machine Learning (ML) and Mathematical Modeling (MM) in Healthcare with Special Focus on Cancer Prognosis and Anticancer Therapy: Current Status and Challenges.

Hassan J, Saeed S, Deka L, Jasim Uddin M, Das D Pharmaceutics. 2024; 16(2).

PMID: 38399314 PMC: 10892549. DOI: 10.3390/pharmaceutics16020260.


Cancer cells possess different isotopic enrichment: Isotopic induced functionalizations of normal DNA mutations leading to cancer.

Little R, Snowton M, Uziel O Heliyon. 2024; 10(1):e23519.

PMID: 38170065 PMC: 10758867. DOI: 10.1016/j.heliyon.2023.e23519.


References
1.
Jimenez-Useche I, Yuan C . The effect of DNA CpG methylation on the dynamic conformation of a nucleosome. Biophys J. 2012; 103(12):2502-12. PMC: 3525854. DOI: 10.1016/j.bpj.2012.11.012. View

2.
Piana S, Bilic A . The nature of the adsorption of nucleobases on the gold [111] surface. J Phys Chem B. 2006; 110(46):23467-71. DOI: 10.1021/jp064438i. View

3.
Zhang J, Wang L, Pan D, Song S, Fan C . DNA hybridization "turns on" electro-catalysis at gold electrodes. Chem Commun (Camb). 2007; (11):1154-6. DOI: 10.1039/b615742d. View

4.
Klysik J, Stirdivant S, Singleton C, Zacharias W, Wells R . Effects of 5 cytosine methylation on the B-Z transition in DNA restriction fragments and recombinant plasmids. J Mol Biol. 1983; 168(1):51-71. DOI: 10.1016/s0022-2836(83)80322-2. View

5.
Lee J, Lee T . Effects of DNA methylation on the structure of nucleosomes. J Am Chem Soc. 2011; 134(1):173-5. PMC: 3257366. DOI: 10.1021/ja210273w. View